Cargando…
A bio-artificial poly([d,l]-lactide-co-glycolide) drug-eluting nanofibrous periosteum for segmental long bone open fractures with significant periosteal stripping injuries
Biodegradable poly([d,l]-lactide-co-glycolide) (PLGA) nanofibrous membrane embedded with two drug-to-polymer weight ratios, namely 1:3 and 1:6, which comprised PLGA 180 mg, lidocaine 20 mg, vancomycin 20 mg, and ceftazidime 20 mg, and PLGA 360 mg, lidocaine 20 mg, vancomycin 20 mg, and ceftazidime 2...
Autores principales: | Chou, Ying-Chao, Cheng, Yi-Shiun, Hsu, Yung-Heng, Yu, Yi-Hsun, Liu, Shih-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792178/ https://www.ncbi.nlm.nih.gov/pubmed/27022261 http://dx.doi.org/10.2147/IJN.S99791 |
Ejemplares similares
-
Biodegradable Vancomycin-eluting Poly[(d,l)-lactide-co-glycolide] Nanofibres for the Treatment of Postoperative Central Nervous System Infection
por: Tseng, Yuan-Yun, et al.
Publicado: (2015) -
Fabrication of Ropivacaine/Dexamethasone-Eluting Poly(D, L-lactide-co-glycolide) Microparticles via Electrospraying Technique for Postoperational Pain Control
por: Shen, Shih-Jyun, et al.
Publicado: (2022) -
Nanofibrous poly(lactide-co-glycolide) membranes loaded with diamond nanoparticles as promising substrates for bone tissue engineering
por: Parizek, Martin, et al.
Publicado: (2012) -
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2017) -
Electrospun Poly(lactide-co-glycolide-co-3(S)-methyl-morpholine-2,5-dione) Nanofibrous Scaffolds for Tissue Engineering
por: Feng, Yakai, et al.
Publicado: (2016)